First Manhattan’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-188
Closed -$3.48K 1560
2022
Q4
$3.48K Hold
188
﹤0.01% 1478
2022
Q3
$2K Hold
188
﹤0.01% 1414
2022
Q2
$4K Hold
188
﹤0.01% 1359
2022
Q1
$6K Buy
+188
New +$9.26K ﹤0.01% 1352
2020
Q4
Sell
-14
Closed 1339
2020
Q3
$0 Sell
14
-111
-89% -$5.33K ﹤0.01% 1344
2020
Q2
$5K Hold
125
﹤0.01% 1238
2020
Q1
$1K Hold
125
﹤0.01% 1328
2019
Q4
$2K Buy
+125
New +$2.05K ﹤0.01% 1242

Other funds holding CRNC

First Manhattan's CRNC Position: Q1 2023 in Review

First Manhattan sold out of Cerence (CRNC) in Q1 2023, closing a stake of 188 shares — an estimated $3.48K sold.

First Manhattan first reported a position in CRNC in Q4 2019 and held it in 8 quarters. The position peaked at $6K in Q1 2022. 228 funds tracked by Wall St. Rank hold CRNC as of Q1 2023.

  • First Manhattan reported no remaining Cerence position as of Q1 2023 after selling out during the quarter.
  • First Manhattan sold 188 Cerence shares in Q1 2023, an estimated $3.48K.
  • First Manhattan first reported a position in Cerence in Q4 2019 and held it in 8 quarters.
  • First Manhattan's Cerence position peaked at $6K in Q1 2022.
  • 228 funds tracked by Wall St. Rank held Cerence as of Q1 2023.

Based on First Manhattan's 13F filing for Q1 2023, filed 15 May 2023.